GB2349217B - Compound screening methods - Google Patents
Compound screening methodsInfo
- Publication number
- GB2349217B GB2349217B GB0009363A GB0009363A GB2349217B GB 2349217 B GB2349217 B GB 2349217B GB 0009363 A GB0009363 A GB 0009363A GB 0009363 A GB0009363 A GB 0009363A GB 2349217 B GB2349217 B GB 2349217B
- Authority
- GB
- United Kingdom
- Prior art keywords
- screening methods
- compound screening
- compound
- methods
- screening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000012216 screening Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/033—Rearing or breeding invertebrates; New breeds of invertebrates
- A01K67/0333—Genetically modified invertebrates, e.g. transgenic, polyploid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
- G01N2333/43526—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
- G01N2333/4353—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes
- G01N2333/43534—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Environmental Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12959699P | 1999-04-15 | 1999-04-15 | |
GBGB9908670.4A GB9908670D0 (en) | 1999-04-15 | 1999-04-15 | Compound screening method |
GBGB9912736.7A GB9912736D0 (en) | 1999-06-01 | 1999-06-01 | Compound screening methods |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0009363D0 GB0009363D0 (en) | 2000-05-31 |
GB2349217A GB2349217A (en) | 2000-10-25 |
GB2349217B true GB2349217B (en) | 2001-04-04 |
Family
ID=27269699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0009363A Expired - Fee Related GB2349217B (en) | 1999-04-15 | 2000-04-14 | Compound screening methods |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1171628A2 (en) |
JP (1) | JP2002541859A (en) |
AU (1) | AU3984700A (en) |
CA (1) | CA2369478A1 (en) |
GB (1) | GB2349217B (en) |
HK (1) | HK1029376A1 (en) |
WO (1) | WO2000063426A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2359360B (en) * | 1999-04-15 | 2002-01-16 | Devgen Nv | Compound screening method |
AU2002218457A1 (en) * | 2000-10-18 | 2002-04-29 | Devgen N.V. | Methods for identifying pesticidal compounds |
JP2006265102A (en) * | 2003-05-08 | 2006-10-05 | Taisho Pharmaceut Co Ltd | METHOD FOR CONTROLLING APOPTOSIS DERIVED FROM TGFbeta |
ATE487135T1 (en) * | 2006-09-18 | 2010-11-15 | Univ North Texas | MULTI-NETWORK NERVE CELL ASSAY PLATFORM WITH PARALLEL RECORDING CAPABILITY |
WO2012168474A1 (en) * | 2011-06-10 | 2012-12-13 | Monell Chemical Senses Center | Novel methods |
EP2775302A1 (en) * | 2013-03-08 | 2014-09-10 | Assistance Publique - Hôpitaux de Paris | Compound-carrier systems for assays in nematodes |
CN114794029B (en) * | 2022-06-09 | 2023-02-28 | 上海大学 | Method for counting number of embryos developed in uterus of caenorhabditis elegans |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1124922A (en) * | 1993-06-03 | 1996-06-19 | 悉尼大学 | Use of natural products and related synthetic compounds for the treatment of cardiovascular disease |
FR2753722A1 (en) * | 1996-09-26 | 1998-03-27 | Smithkline Beecham Lab | METHOD FOR DETECTING CARDIAC RELAXATION MODULATORS AND MODULATORS THUS OBTAINED |
WO1998051351A1 (en) * | 1997-05-15 | 1998-11-19 | The General Hospital Corporation | Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
US6329566B1 (en) * | 1997-05-29 | 2001-12-11 | The General Hospital Corporation | Methods for the detection, treatment, and prevention of neurodegeneration |
WO1999004636A1 (en) * | 1997-07-22 | 1999-02-04 | The General Hospital Corporation | Evaluation of, delivery of, and use of agents to treat heart disorders |
-
2000
- 2000-04-14 EP EP00919102A patent/EP1171628A2/en not_active Withdrawn
- 2000-04-14 JP JP2000612503A patent/JP2002541859A/en active Pending
- 2000-04-14 WO PCT/IB2000/000558 patent/WO2000063426A2/en not_active Application Discontinuation
- 2000-04-14 GB GB0009363A patent/GB2349217B/en not_active Expired - Fee Related
- 2000-04-14 CA CA002369478A patent/CA2369478A1/en not_active Abandoned
- 2000-04-14 AU AU39847/00A patent/AU3984700A/en not_active Abandoned
- 2000-12-16 HK HK00108142A patent/HK1029376A1/en not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
J. Biol. Chem., Feb. 1999, 274(7), pp.4254-4258 - Kraev et al. * |
Also Published As
Publication number | Publication date |
---|---|
WO2000063426A3 (en) | 2001-02-08 |
EP1171628A2 (en) | 2002-01-16 |
JP2002541859A (en) | 2002-12-10 |
GB0009363D0 (en) | 2000-05-31 |
AU3984700A (en) | 2000-11-02 |
HK1029376A1 (en) | 2001-03-30 |
WO2000063426A2 (en) | 2000-10-26 |
CA2369478A1 (en) | 2000-10-26 |
GB2349217A (en) | 2000-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0201142A2 (en) | Compound screening method | |
GB9922352D0 (en) | Screening method | |
GB9924797D0 (en) | Compound | |
GB2349217B (en) | Compound screening methods | |
EP1175268A4 (en) | Screening equipment | |
GB9920919D0 (en) | Novel compound | |
GB9923075D0 (en) | Screening method | |
EP1237001A4 (en) | Screening method | |
GB2359627B (en) | Compound screening method | |
GB9902696D0 (en) | Screening methods | |
GB9921928D0 (en) | Compound | |
GB9908676D0 (en) | Method for screening compounds | |
GB9914342D0 (en) | Compound | |
GB0031557D0 (en) | Compound | |
GB0031563D0 (en) | Compound | |
GB9930255D0 (en) | Screening method | |
GB9921929D0 (en) | Compound | |
GB9929255D0 (en) | Compound | |
GB9912736D0 (en) | Compound screening methods | |
GB9928430D0 (en) | Screening | |
EP1209240A4 (en) | Novel compound f-15078 | |
GB9908670D0 (en) | Compound screening method | |
GB9924965D0 (en) | Compound | |
GB9915225D0 (en) | Screening method | |
GB9915226D0 (en) | Screening method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20090414 |